02-BMT-139: A Randomized Controlled Trial of Posaconazole (SCH 56592) vs. Standard Azole Therapy for the Prevention of Invasive Fungal Infections Among High-Risk Neutropenic Patients (P01899-25)

Grants and Contracts Details

StatusFinished
Effective start/end date7/1/036/30/08

Funding

  • Schering Plough Co: $12,910.00